Format

Send to

Choose Destination
PLoS One. 2010 Nov 10;5(11):e13926. doi: 10.1371/journal.pone.0013926.

Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.

Author information

1
Medical Proteomics Laboratory, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

Abstract

BACKGROUND:

Mutation of the epidermal growth factor receptor (EGFR) results in a discordant cell signaling, leading to the development of various diseases. However, the mechanism underlying the alteration of downstream signaling due to such mutation has not yet been completely understood at the system level. Here, we report a phosphoproteomics-based methodology for characterizing the regulatory mechanism underlying aberrant EGFR signaling using computational network modeling.

METHODOLOGY/PRINCIPAL FINDINGS:

Our phosphoproteomic analysis of the mutation at tyrosine 992 (Y992), one of the multifunctional docking sites of EGFR, revealed network-wide effects of the mutation on EGF signaling in a time-resolved manner. Computational modeling based on the temporal activation profiles enabled us to not only rediscover already-known protein interactions with Y992 and internalization property of mutated EGFR but also further gain model-driven insights into the effect of cellular content and the regulation of EGFR degradation. Our kinetic model also suggested critical reactions facilitating the reconstruction of the diverse effects of the mutation on phosphoproteome dynamics.

CONCLUSIONS/SIGNIFICANCE:

Our integrative approach provided a mechanistic description of the disorders of mutated EGFR signaling networks, which could facilitate the development of a systematic strategy toward controlling disease-related cell signaling.

PMID:
21085658
PMCID:
PMC2978091
DOI:
10.1371/journal.pone.0013926
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center